2018 BioTech Life Science Medicare 
Health Populi
JULY 11, 2019
This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries. The objective of this investment round is to further scale GNS solutions that personalize medicines to individual patients.
Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MARCH 19, 2019
Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. To that point, IRI’s Kristin Hornberger presented new data on retail health market performance in 2018. Consumer health as a category was $45 billion in 2018, growing at 2.1%.
Health Populi
OCTOBER 28, 2019
The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018. A recent study on politics and health care spending in the U.S.
Health Populi
MAY 14, 2018
Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement. Incentives for lowering list prices for medicines, such as FDA requiring that drug companies include list prices in ads and bringing more transparency to Medicare drug pricing and generic competition, and.
Expert insights. Personalized for you.
220 
Let's personalize your content